Contact: Sharon Bournes
Assoc. Director, Marketing Communications
JUPITER, FL, September 9, 2015 – Louis Perrault, MD, Ph.D., FRCSC, FACS, a leading cardiovascular and thoracic surgeon from the Montreal Heart Institute, recently presented the study design and progress for a multicenter, randomized, prospective study with DuraGraft.
DuraGraft is first-in-class and the only CE marked product intended for the preservation, storage and flushing of vascular conduits, which is a pivotal step in coronary artery bypass and peripheral bypass graft surgeries.
The multi-center study is designed to analyze vein graft behavior and remodeling over a 12-month period in patients undergoing CABG surgery. The within-patient design evaluates two saphenous vein grafts in the same patient: one treated with DuraGraft versus one treated with the Standard of Care (heparin-dosed saline). The difference in changes in wall thickness and lumen diameter between the paired vein grafts are assessed using Multi-detector Computed Tomography (MDCT) angiography at various time points post CABG.
“The study results will provide additional information to better understand the influence of intraoperative vein graft preservation solutions such as DuraGraft and their impact in preventing vein graft disease and patient outcomes”, says Perrault.
About Somahlution, LLC.
Somahlution is a global leader in the development and commercialization of innovative, high value-added solutions to advance clinical performance, define standard of care and improve patient outcomes. Using patented and proprietary technologies, Somahlution is dedicated to providing medical products focused on Ischemia Reperfusion Injury (IRI) to improve healthcare delivery to patients around the world. The company’s flagship product, DuraGraft is the first Endothelial Damage Inhibitor (EDI) developed to address the pivotal step of vascular conduit handling and storage in bypass and vascular surgeries. For more information on the company, please visit www.somahlution.com.
# # #
Back to the latest news